Aerovate Therapeutics shares owned by Cormorant Asset Management
Quarter-by-quarter ownership of Aerovate Therapeutics (AVTE) shares owned by Cormorant Asset Management
from 13F filings
Historical chart of Cormorant Asset Management investment in Aerovate Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aerovate Therapeutics held by Cormorant Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Aerovate Therapeutics by Cormorant Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $27M | 1.2M | 22.63 |
| 2023-09-30 | $21M | 1.6M | 13.57 |
| 2023-06-30 | $27M | 1.6M | 17.15 |
| 2023-03-31 | $32M | 1.6M | 20.17 |
| 2022-12-31 | $57M | 2.0M | 29.30 |
| 2022-09-30 | $39M | 2.3M | 16.58 |
| 2022-06-30 | $27M | 1.7M | 15.63 |
| 2022-03-31 | $34M | 1.8M | 18.33 |
| 2021-12-31 | $22M | 1.8M | 11.79 |
| 2021-09-30 | $42M | 2.0M | 20.66 |
| 2021-06-30 | $45M | 2.0M | 21.97 |
More positions owned by Cormorant Asset Management
View all positions for Cormorant Asset Management